Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Hoffmann-La Roche
Advanced Accelerator Applications
Daiichi Sankyo
Bayer
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Jazz Pharmaceuticals
Incyte Corporation
Incyte Corporation
Partner Therapeutics, Inc.
Seagen Inc.
Merck Sharp & Dohme LLC
Novartis
QED Therapeutics, a BridgeBio company
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Daiichi Sankyo